Starting a new treatment can feel both hopeful and nerve-wracking — totally understandable! BRUKINSA (zanubrutinib) is a BTK inhibitor approved for MCL in people who've had at least one prior treatment. It's taken as a pill once or twice daily, which is convenient compared to IV treatments.
Here are some common side Show Full Answer
Starting a new treatment can feel both hopeful and nerve-wracking — totally understandable! BRUKINSA (zanubrutinib) is a BTK inhibitor approved for MCL in people who've had at least one prior treatment. It's taken as a pill once or twice daily, which is convenient compared to IV treatments.
Here are some common side effects to be aware of:
- Fatigue
- Bruising
- Diarrhea
- Cough
- Rash
- Low blood cell counts (anemia or neutropenia)
There are also some rarer but more serious risks to keep on your radar:
- Bleeding or hemorrhage
- Infections
- Irregular heartbeat
- Liver changes
- Skin-related secondary cancers It's really important to stay in close contact with your care team about any new or changing symptoms while on BRUKINSA. Don't hesitate to flag even minor things — your oncologist needs the full picture to keep your treatment on track.
Many MyLymphomaTeam members share their personal experiences with treatments like this one, so connecting with others going through the same thing can be really reassuring. You're not alone in this! 💙
May 15
Join
Your Privacy Choices
